ABVC BioPharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones ABVC BioPharma Achieved its First Operational Profit, with a 102% Improvement over the Third Quarter of Last Year.Incremental Payments Received based on Executed Global Licensing Agreements that could...